ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
BODIPY Photocage-Based Injectable Hydrogel for Light-Controlled Nanoparticle Release.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Light-controlled release of therapeutics holds great promise for improving patient compliance with treatment plans against many leading diseases and could contribute to a better quality of life for people suffering from chronic conditions. However, insufficient tissue penetration of light largely limits the in vivo applications of photoresponsive therapeutics. With the aim to circumvent this limitation and to work within tissue depths that are pragmatically accessible to light, we developed an injectable and photodegradable hydrogel that could enable controlled drug delivery in subcutaneous tissue. In this work, we describe a hydrogel formulation consisting of a 2-arm photocage bearing azide and a BCN-terminated 4-arm PEG. Gelation takes place in minutes upon mixing the two components via strain-promoted azide-alkyne cycloaddition (SPAAC). Both gel precursors are made water-soluble and exhibit low viscosity prior to complete gelation, and the pre-gel is easily injectable through 23G needles. Photocage photocleavage and consequent gel degradation could be precisely controlled with green light irradiation. We further showed that nanoparticles can be successfully encapsulated into the gel and subsequently photo-released. The full operation process was demonstrated in an ex vivo porcine model and the acute biocompatibility of gel injection and degradation was evaluated in healthy human skin cultured ex vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.